Oligoribonucleotid- und Ribozym-Analoga mit terminalen 3'-3'-bzw.5'-5'-Verknüpfungen
申请人:HOECHST AKTIENGESELLSCHAFT
公开号:EP0593901B1
公开(公告)日:1997-04-16
US6420546B1
申请人:——
公开号:US6420546B1
公开(公告)日:2002-07-16
Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages
申请人:Aventis Pharma Deutschland GmbH
公开号:US06420546B1
公开(公告)日:2002-07-16
The invention relates to oligoribonucleotide analogs with terminal 3′—3′ and/or 5′—5′ internucleotide linkages. This modification stabilizes the molecules altered in this way, including ribozymes, without adversely altering their properties, including, where appropriate, catalytic activities.